The coexistence of psychiatric symptomatology among individuals receiving longer-term treatment for alcohol use disorders has been well-established; however, less is known about comorbidity among individuals receiving alcohol detoxification. Using the Brief Symptom Inventory (BSI; Derogatis, 1992), we compared psychiatric symptomatology among 815 individuals receiving short-term detoxification services with normative data from nonpatients, psychiatric patients, and out-oftreatment individuals using street drugs. Findings revealed that individuals in the current sample reported a wide range of psychiatric symptoms with over 80% meeting BSI criteria for diagnosable mental illness. These BSI scores were significantly more severe than those reported by out-oftreatment individuals using street drugs and most closely resembled BSI scores reported for adult psychiatric inpatients. Findings suggest that routine screening for severe mental health symptoms appears warranted in detoxification units. Such screening would greatly increase the chance that coexistence of substance use and other psychiatric disorders would be properly addressed in ongoing treatment.
Introduction
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have been found to have very high rates of psychiatric comorbidity (e.g., Castel, Rush, Urbanoski, & Toneatto, 2006; Johnson, Brems, & Burke, 2002; Watkins et al., 2004) . However, less is known about psychiatric symptomatology among individuals with severe and sustained alcohol abuse or dependence who are receiving short-term detoxification, but no additional treatment services. The purpose of this study was to assess the degree of psychopathology as measured by the Brief Symptom Inventory (Derogatis, 1992) among individuals seeking detoxification services at a short-term, alcohol detoxification program.
Method

Setting and Participants
Data were collected from 815 individuals receiving services at an alcohol detoxification unit located in Anchorage, Alaska. This unit is designed to provide a four-day intervention to detoxify individuals from alcohol and to assess them for any additional needed treatment. Average length of stay for the participants was 4.84 days (SD=1.28). Table 1 provides demographic information about the 815 participants.
Instrumentation
Brief Symptom Inventory (BSI; Derogatis, 1992) . The BSI consists of 53 symptoms drawn from the Symptom Checklist-90-R (Derogatis, 1992) Scoring is accomplished by adding ratings for subscale items and dividing by the number of items. These mean raw scores can be transformed into T-scores (mean of 50 and standard deviation of 10) separately for women and men, based on relevant norms tables (adult, adolescent, inpatient, and outpatient). The following two criteria have been established for designating a protocol as being positive for diagnosable psychopathology based on adult, nonpatient norms: a) T-score for GSI of 63 or greater, or b) T-scores of 63 or greater on two or more subscales (Derogatis, 1992) . The instrument has demonstrated good psychometric properties, with adequate reliability and validity (Derogatis, 1992; Morlan & Tan, 1998) .
Procedure
The BSI was completed as part of the detoxification unit's regular intake assessment and after consumers provided informed consent for treatment and use of data for research and evaluation purposes; all research procedures were conducted in compliance with the Institutional Review Board at the University of Alaska Anchorage. The BSI and other intake forms were completed as soon as staff members believed consumers were sufficiently sober to give consent, understand instructions, and participate in the assessment process. For most consumers, the assessment process was completed on the second day of services.
Results
Comparisons with Normative Samples
To compare whether the BSI scores obtained for the current sample differed from those of four normative samples (adolescent non-patients, adult non-patients, psychiatric inpatients, and psychiatric outpatients) provided by Derogatis (1992) , independent two-tailed t-tests were calculated. Table 2 provides means and standard deviations and Table 3 provides t-test results. Significant differences (p<.001) were revealed between the current sample and the normative adult and adolescent non-patients on all but one subscale (adolescent non-patients for Hostility subscale). On all comparisons, the current sample of individuals receiving alcohol detoxification treatment services provided more pathological symptom ratings.
The current sample differed significantly from psychiatric outpatients on four of nine subscales (Somatization, Phobic Anxiety, Paranoid Ideation, and Psychoticism) and two of three global scales (Global Severity Index and Positive Symptom Total) . For all significant differences, the current sample provided higher ratings than the normative psychiatric outpatient sample. The current sample differed significantly from psychiatric inpatients only on the Somatization subscale, on which the current sample provided higher ratings.
Comparisons with Out-of-Treatment Drug Users Sample
Additional independent two-tailed t-tests were calculated to compare BSI scores obtained from the current sample with BSI scores from a sample of 582 injection drug-using individuals not currently in treatment. These out-of-treatment drug users were participants in a NIDA-funded project designed to determine the effects of a needle exchange program (Fisher, Fenaughty, Cagle, & Wells, 2003) . Additional details about this sample are available in Johnson, Neal, Brems, and Fisher (2006) . Table 2 provides means and standard deviations and Table 3 provides t-test results. Results indicate that all BSI subscales and global indices obtained from individuals receiving alcohol detoxification treatment services were significantly higher than scores obtained from out-of-treatment, injection drug-using individuals.
Positive Diagnostic Indicators
Participants were categorized using the two criteria established by Derogatis (1992; see above) for identifying protocols as demonstrating diagnosable psychopathology. Table 4 provides the percentages of participants who had a T-score of 63 or greater on each of the nine SCL-90-R subscales. Based on the criterion of having T-scores of 63 or greater on two or more subscales, 81.3% of the men and 82.6% of the women were diagnosable with comorbid psychopathology. Based on the criterion of a GSI T-score of 63 or greater, 75.3% of the men and 75.8% of the women produced protocols that were sufficiently severe to suggest a diagnosis of comorbid psychopathology.
Discussion
Prior research has indicated that substance abusers with severe psychopathology are more likely to receive treatment at mental health facilities and those with less severe psychopathology are more likely to receive treatment at substance abuse facilities (Primm et al., 2000) . However, current findings suggest that this conclusion based on prior research may not be generalizable to individuals in detoxification. The individuals in this sample reported psychiatric symptoms of great acuity and wide range and an exceedingly high proportion of the sample (over 80%) met BSI criteria for diagnosable mental illness. Clearly, this suggests a large proportion of individuals in detoxification suffer from great psychiatric distress that warrants attention. Further, these findings provide evidence that individuals in alcohol detoxification are symptomatically significantly different from other individuals who are abusing or dependent on alcohol and from individuals in the general population or in the psychiatric population.
The implications of this finding could potentially be far-reaching for agencies providing detoxification services. It appears crucial to identify additional psychopathology among individuals in alcohol detoxification as such symptoms are likely to complicate treatment and evaluation plans. It may be erroneously assumed by providers that the prime goal of detoxification services is the initiation of sustained sobriety, and that comorbid psychiatric symptoms will be relieved on their own, or will significantly diminish, once that objective is achieved. Rather, more positive overall outcomes are likely if treatment plans are designed to help alleviate both the alcohol use disorder and any comorbid psychological symptoms (Brems & Johnson, 1997; Grant et al., 2004) . Attention to psychiatric symptoms among individuals in detoxification may greatly enhance their outcomes both with regard to sobriety and mental health, especially if detection is timed at the onset of their stay in detoxification and can thus be considered when additional treatment plans are made.
Based on findings from this study, routine screening for severe mental health symptoms appears warranted in detoxification units. Individuals identified with high psychiatric distress could then be assessed more thoroughly through a psychiatric interview, a process that would greatly increase the chance that true coexistence of substance use and other psychiatric disorders would be properly addressed in ongoing treatment. Care will need to be taken to understand the psychiatric symptoms and distress of individuals in detoxification in their greater context of symptom presentation. Even though BSI-based comorbidity rates are high, it must be understood that they are not always reflective of definite coexistence of an alcohol use and other psychiatric disorder for each screened individual. It is possible that some acute mental health symptoms reported are directly related to the detoxification process and ameliorate upon successful completion of detoxification. However, ongoing observation during the individual's stay on the detoxification unit to differentiate temporary from ongoing psychiatric distress will be crucial to the successful long-term treatment of each individual. 
